<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A double blind controlled trial has been conducted in 40 patients to compare the therapeutic effects of <z:chebi fb="2" ids="8378">prednisolone</z:chebi> metasulphobenzoate enemas with those of <z:chebi fb="2" ids="8378">prednisolone</z:chebi>-21-phosphate enemas </plain></SENT>
<SENT sid="1" pm="."><plain>Both enemas brought about improvement in symptoms and sigmoidoscopic appearances in more than 70% of patients treated </plain></SENT>
<SENT sid="2" pm="."><plain>The absorption of <z:chebi fb="2" ids="8378">prednisolone</z:chebi> from the metasulphobenzoate enema in three patients was less than from the 21-phosphate enema </plain></SENT>
<SENT sid="3" pm="."><plain>In view of the low plasma <z:chebi fb="2" ids="8378">prednisolone</z:chebi> concentrations obtained, there are theoretical advantages in using a poorly absorbed enema to avoid the possibility of systemic steroid effects in patients requiring long term steroid treatment </plain></SENT>
</text></document>